Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1156 POSTS

Exclusive articles:

SKN | Malaysian Aesthetic Clinic Operator I Bella Perfect Files and Sets Terms for $9 Million US IPO

I Bella Perfect Group, a Malaysia-based operator of aesthetic and beauty clinics, has filed and set terms for a modest $9 million US IPO,...

SKN | Social Commerce Partners Corp Unit Holds Near Trust Value as Technical Signals Turn Firm

Social Commerce Partners Corp Unit (SCPQU) is trading close to its trust value around $10, showing limited volatility but increasingly constructive technical signals. While...

SKN | SPAC Abony Acquisition I files for a $200 million IPO, targeting defense, computing, and software

SPAC Abony Acquisition I has filed to raise $200 million through an initial public offering (IPO), aiming to identify and acquire companies in the...

SKN | Hong Kong-based apparel producer Riverstone files and sets terms for a $15 million US IPO

Hong Kong-based apparel producer Riverstone has filed to launch a $15 million initial public offering (IPO) in the United States, aiming to raise capital...

SKN | Victoria’s Secret & Co. Reinforces Governance and Brand Focus Ahead of 2026 Earnings

Victoria's Secret & Co. continues to reposition itself as a focused global retailer of women’s intimate apparel and beauty products as it heads toward...

Breaking

SKN | American Century Investments Launches Emerging Markets Insights ETF on Nasdaq

Key Points: American Century Investments has launched the Emerging...

SKN | ETF Launches and Hilton’s Nasdaq Transfer Shape November 5 Listings

Key Takeaways: The November 5 IPO calendar listed five...

SKN | American Ventures Acquisition I Cuts Proposed IPO Size by 25% to $75 Million

American Ventures Acquisition I, a blank check company targeting...

SKN | Rezera Sets Terms for $200 Million IPO as GSK Signals Up to $25 Million Investment

Rezera, a clinical-stage biotechnology company developing oral NLRP3 inhibitors...
spot_imgspot_img